SCHEMBL19169218

SCHEMBL19169218

Cc1nc(-n2c3ccccc3c3ccccc32)c2c(n1)sc1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR55 Q9Y2T6 2/20 0.48
▸ ELANE P08246 1/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ LMNA P02545 3/20 0.38
▸ TSHR P16473 3/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ ADK P55263 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ CNR2 P34972 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CNR1 P21554 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16905633 0.84 ELANE (0.39) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL19161630 0.82 ELANE (0.36) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL16905627 0.81 KDM4E (0.39) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL16905629 0.78 KDM4E (0.38) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL16919872 0.77 HRH4 (0.45) KDM4EMAPTALDH1A1TSHRHSD17B10
SCHEMBL19170141 0.77 ELANE (0.39) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL16905636 0.77 ALDH1A1 (0.42) KDM4EMAPTALDH1A1LMNATSHR
SCHEMBL19118255 0.75 ELANE (0.43) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL19169781 0.75 KDM4E (0.39) GPR55ELANEKDM4EMAPTALDH1A1
SCHEMBL19170194 0.75 KDM4E (0.39) GPR55ELANEKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, NOS1, NOLC1 GPR55 3466/4885ELANE 2532/4885KDM4E 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback